4.5 Article

Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer

期刊

CLINICAL AND EXPERIMENTAL IMMUNOLOGY
卷 194, 期 1, 页码 39-53

出版社

WILEY
DOI: 10.1111/cei.13183

关键词

CD8-positive T lymphocytes; cell exhaustion; DNA methylation; perforin; tissue-resident memory T cells; urinary bladder neoplasms

资金

  1. Swedish Cancer Society (Cancerfonden)
  2. Regional Research Council in Uppsala-Orebro region, Sweden (RFR in Uppsala-Orebro)
  3. Swedish Research Council
  4. Cancer Research Foundation in Norrland, Umea, Sweden
  5. Stiftelsen Emil Anderssons fond for medicinsk forskning, Sundsvall, Sweden

向作者/读者索取更多资源

Tissue-resident memory T (T-RM) cells are CD8(+) T lymphocytes that reside in the tissues, including tumours. This T cell subset possesses a magnitude of cytotoxicity, but its epigenetic regulation has not been studied. Here, we investigate the impact of perforin DNA methylation in T-RM cells and correlate it with their functional potential. Fifty-three urothelial urinary bladder cancer (UBC) patients were recruited prospectively. The DNA methylation status of the perforin gene (PRF1) locus in T-RM cells was investigated by pyrosequencing. Flow cytometry with ViSNE analysis and in-vitro stimulation were used to evaluate T-RM cell phenotypes. We discovered that tumour T-RM cells have low DNA methylation in the PRF1 locus (329% methylation), which corresponds to increased numbers of perforin-expressing T-RM cells. Surprisingly, programmed cell death 1 (PD-1) expression is high in tumour T-RM cells, suggesting exhaustion. Following interleukin-15 and T cell receptor stimulation, perforin and T-bet expressions are enhanced, indicating that T-RM cells from tumours are not terminally exhausted. Moreover, a high number of T-RM cells infiltrating the tumours corresponds to lower tumour stage in patients. In conclusion, T-RM cells from UBC tumours are epigenetically cytotoxic with signs of exhaustion. This finding identifies T-RM cells as potential new targets for cancer immunotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据